rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Oxford Vaccine Group

Rediff.com  »  News  »   Oxford Vaccine Group

  News for Oxford Vaccine Group

  • News
  • Business

Oxford vaccine doing 'everything expected': Study

The Oxford University COVID-19 vaccine undergoing Phase III clinical trials with British pharma giant AstraZeneca is doing 'everything expected' which means good news in the fight against the......

AstraZeneca admits in court: Covishield causes TTS

United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is......

Covishield side effects: Doctors' group urges govt to review all Covid vax

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its COVID vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the......

New all-in-one vaccine may prove effective against all coronaviruses

A team of scientists from the world's leading universities has developed a new all-in-one vaccine that they hope can protect humans against a broad range of coronaviruses, including ones that are......

Oxford vaccine should be effective against new variant: Report

The coronavirus vaccine developed by Oxford University and AstraZeneca “should be” effective against the highly transmissible new strain of the virus, a United Kingdom media report said......

Vax king Poonawalla shells out Rs 1,400 crore to snap up London villa

Serum Institute of India chief Adar Poonawalla will pay £138 million (about Rs 1,444 crore) for a Mayfair mansion in London in one of the city’s most expensive home sales of the year,......

Serum Institute to produce COVID-19 vaccine by yearend

'The challenge will be making sure its efficacy is high.''If a vaccine is only 50 to 60 per cent efficient, it's a double-edged sword.' Adar Poonawalla, chief executive officer, Serum Institute of......

Meet Adar Poonawala, India's COVID-19 vaccine man

Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

How govt plans to distribute Covid-19 vaccine

The procurement and distribution will be centralised though  the government is yet to take a call on the initial number of doses that will be procured. India plans to create a digital......

Top Coverage News


World Test Championship 2023

India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

Here are news, updates and coverage from violence hit Manipur.

IPL 2023

Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z